top of page

Bonjour Europe

Find the latest drug approvals in Europe, HTA assessments, healthcare news

European Commission Authorizes RINVOQ for Severe Alopecia Areata

21 hours ago

European Commission Grants Approval for Oral Semaglutide in Weight Management

Jul 16

Enhertu Gains EU Tumour‑Agnostic Approval For HER2‑Positive Metastatic Solid Tumours | iPharmaCenter

Jun 29

Hospital and Drug Costs Outpace Contributions in Germany, Raising Pressure on Pharma Pricing

Jun 27

June 2026: CHMP Signals New Options in CLL, TNBC and Multiple Myeloma

Jun 27

Sanofi’s Cenrifki Wins EU Approval for Non-Relapsing Secondary Progressive MS | iPharmaCenter

Jun 23

EU Launches Era of Centralized HTA with First Joint Clinical Assessment of Ojemda | iPharmaCenter

Jun 11

Spain Explores Italy’s HTA Model to Advance EU HTA Regulation Implementation | iPharmaCenter

May 27

Germany Advances Pharmacy Reform with ApoVWG Law to Strengthen Rural Access and Healthcare Services

May 25

Europe’s Pharmaceutical Strategy in a Changing Global Order: Germany and France Push for Resilience and Competitiveness | iPharmaCenter

May 22

New Hope for GVHD Patients as Rezurock Wins EU Approval | iPharmaCenter

New Hope for GVHD Patients as Rezurock Wins EU Approval | iPharmaCenter

New Hope for GVHD Patients as Rezurock Wins EU Approval | iPharmaCenter

Apr 2

Amgen’s Uplizna wins European Commission approval for generalized myasthenia gravis | iPharmaCenter

Feb 17

GSK’s ultra‑long‑acting IL‑5 biologic Exdensur wins EU approval for severe asthma and CRSwNP | iPharmaCenter

Feb 17

GSK’s RSV Vaccine, Arexvy is now approved for all adults in Europe | iPharmaCenter

GSK’s RSV Vaccine, Arexvy is now approved for all adults in Europe | iPharmaCenter

GSK’s RSV Vaccine, Arexvy is now approved for all adults in Europe | iPharmaCenter

Feb 1

EMA Begins Review of Trastuzumab Deruxtecan Plus Pertuzumab as First-Line Therapy for HER2 Positive Metastatic Breast Cancer | iPharmaCenter

Jan 20

Germany’s Federal Ministry of Health (BMG) initiated two research funding projects to strengthen women's health | iPharmaCenter

Jan 17

European Commission grants approval to Sanofi's Wayrilz for refractory immune thrombocytopenia | iPharmaCenter

Dec 29, 2025

Johnson & Johnson Secures European Commission Approval for IMAAVY (Nipocalimab) to Treat Generalised Myasthenia Gravis

Dec 5, 2025

US–Swiss Tariff Cap Impact on Pharma: How the New US–Swiss Tariff Cap Shapes Pharma and Health Security

Dec 2, 2025

EU clears Dupixent as first targeted CSU therapy in over a decade | iPharmaCenter

Nov 29, 2025

BMS' Breyanzi CAR-T Therapy Approved for Treating Mantle Cell Lymphoma | iPharmaCenter

Nov 25, 2025

European Drug Approvals | CHMP Positive Opinions | January 2025 | iPharmaCenter

Feb 3, 2025

Rybrevant plus Lazcluze approved in Europe for EGFR-NSCLC; showed improvement over Tagrisso | iPharmaCenter

Jan 2, 2025

Novartis’ Kisqali Gains European Commission Approval for Broader Use in Early Breast Cancer Patients at High Risk of Recurrence | iPharmaCenter

Dec 1, 2024

EMA Drug Approvals 2024 | CHMP Positive Opinion | October 2024 | iPharmaCenter

Oct 19, 2024

European Commission Greenlights Keytruda and Padcev Combo as First-Line Treatment for Advanced Urothelial Carcinoma | iPharmaCenter

Sep 3, 2024

European Commission Expands Approval for GSK's Arexvy, the First RSV Vaccine for Adults Aged 50-59 at Increased Risk | iPharmaCenter

Sep 1, 2024

Roche aims PNH market with SC PiaSky, aims to target AZ's Ultomiris market | iPharmaCenter

Aug 29, 2024

European Union Approves Ordspono for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma | iPharmaCenter

Aug 27, 2024

Leqembi (lecanemab) Approved in Great Britain for Early-Stage Alzheimer's Disease | iPharmaCenter

Leqembi (lecanemab) Approved in Great Britain for Early-Stage Alzheimer's Disease | iPharmaCenter

Leqembi (lecanemab) Approved in Great Britain for Early-Stage Alzheimer's Disease | iPharmaCenter

Aug 24, 2024

The European Commission Grants Approval for Tepkinly for a New Indication in Treating Relapsed/Refractory Follicular Lymphoma in Adults | iPharmaCenter

Aug 24, 2024

Dupixent (Dupilumab) Gains EU Approval as the First Targeted Therapy for COPD

Jul 4, 2024

Committee for Medicinal Products for Human Use | CHMP Positive Opinion | June | Europe Drug Approvals | 2024 | iPharmaCenter

Jul 2, 2024

European Commission Approves Roche's Alecensa as First Targeted Adjuvant Therapy for Early-Stage ALK-Positive Lung Cancer | 2024 | iPharmaCenter

Jun 10, 2024

Biogen Gains European Commission Approval for QALSODY (tofersen), a Novel Therapy for a Rare Genetic Form of ALS | EMA Drug Approvals | 2024 | iPharmaCenter

May 31, 2024

EMA Drug Approvals | Europe drug approvals | 2024 | iPharmaCenter

EMA Drug Approvals | Europe drug approvals | 2024 | iPharmaCenter

EMA Drug Approvals | Europe drug approvals | 2024 | iPharmaCenter

Apr 23, 2024

EMA Drug Approvals - CHMP Positive Opinions | March 2024 | iPharmaCenter

EMA Drug Approvals - CHMP Positive Opinions | March 2024 | iPharmaCenter

EMA Drug Approvals - CHMP Positive Opinions | March 2024 | iPharmaCenter

Mar 24, 2024

CHMP Positive Opinions | February | 2024 | iPharmaCenter

CHMP Positive Opinions | February | 2024 | iPharmaCenter

CHMP Positive Opinions | February | 2024 | iPharmaCenter

Feb 28, 2024

Medicines and Healthcare products Regulatory Agency | UK Drug approvals | News | iPharmaCenter

Medicines and Healthcare products Regulatory Agency | UK Drug approvals | News | iPharmaCenter

Medicines and Healthcare products Regulatory Agency | UK Drug approvals | News | iPharmaCenter

Nov 17, 2023

EMA Drug Approvals | CHMP Positive Opinions in October 2023 | Europe drug approvals | iPharmaCenter

EMA Drug Approvals | CHMP Positive Opinions in October 2023 | Europe drug approvals | iPharmaCenter

EMA Drug Approvals | CHMP Positive Opinions in October 2023 | Europe drug approvals | iPharmaCenter

Oct 17, 2023

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

Sep 27, 2023

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

Jul 26, 2023

Switzerland drug approvals | Swissmedic news | Blogs | 2023 | iPharmaCenter

Jul 10, 2023

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

May 16, 2023

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

Feb 28, 2023

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

Jan 26, 2023

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

Jan 6, 2023

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

Oct 9, 2022

Opdualag was approved for unresectable/metastatic melanoma | LAG-3 inhibitors | Mode of action

Sep 19, 2022

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

Aug 29, 2022

bottom of page